Anna Vidal‐Alabró

549 total citations
28 papers, 401 citations indexed

About

Anna Vidal‐Alabró is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Anna Vidal‐Alabró has authored 28 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Transplantation, 12 papers in Pediatrics, Perinatology and Child Health and 10 papers in Molecular Biology. Recurrent topics in Anna Vidal‐Alabró's work include Renal Transplantation Outcomes and Treatments (14 papers), Pharmacological Effects and Toxicity Studies (12 papers) and HIV/AIDS drug development and treatment (5 papers). Anna Vidal‐Alabró is often cited by papers focused on Renal Transplantation Outcomes and Treatments (14 papers), Pharmacological Effects and Toxicity Studies (12 papers) and HIV/AIDS drug development and treatment (5 papers). Anna Vidal‐Alabró collaborates with scholars based in Spain, United Kingdom and China. Anna Vidal‐Alabró's co-authors include Ramón Bartrons, José C. Perales, Alícia G. Gómez-Valadés, Jordi Bermúdez, Maria Molas, Miguel Chillón, Andrés Méndez‐Lucas, Núria Lloberas, Jordi Boada and Pere Fontova and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and International Journal of Molecular Sciences.

In The Last Decade

Anna Vidal‐Alabró

28 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Vidal‐Alabró Spain	10	189	112	67	66	51	28	401
Jancy Stephen Canada	7	162 0.9×	79 0.7×	12 0.2×	75 1.1×	11 0.2×	8	366
Tom Smith United States	9	108 0.6×	83 0.7×	33 0.5×	29 0.4×	15 0.3×	17	406
Hongyan Zhang China	12	135 0.7×	40 0.4×	25 0.4×	23 0.3×	7 0.1×	34	387
Thipaporn Tharavanij Thailand	11	89 0.5×	301 2.7×	22 0.3×	38 0.6×	240 4.7×	31	477
Nadezda V. Andrianova Russia	13	232 1.2×	65 0.6×	5 0.1×	98 1.5×	19 0.4×	43	482
Patrícia M. Nunes Portugal	9	170 0.9×	36 0.3×	4 0.1×	121 1.8×	58 1.1×	21	376
T. C. Wascher Austria	13	57 0.3×	70 0.6×	12 0.2×	112 1.7×	105 2.1×	21	400
Sirilaksana Kunjara United Kingdom	13	154 0.8×	117 1.0×	4 0.1×	66 1.0×	86 1.7×	40	536
Marián Kukan Slovakia	10	50 0.3×	186 1.7×	14 0.2×	62 0.9×	41 0.8×	16	376
Chi‐Feng Hung Taiwan	12	145 0.8×	99 0.9×	4 0.1×	44 0.7×	27 0.5×	25	476

Countries citing papers authored by Anna Vidal‐Alabró

Since Specialization

Citations

This map shows the geographic impact of Anna Vidal‐Alabró's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Vidal‐Alabró with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Vidal‐Alabró more than expected).

Fields of papers citing papers by Anna Vidal‐Alabró

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Vidal‐Alabró. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Vidal‐Alabró. The network helps show where Anna Vidal‐Alabró may publish in the future.

Co-authorship network of co-authors of Anna Vidal‐Alabró

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Vidal‐Alabró. A scholar is included among the top collaborators of Anna Vidal‐Alabró based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Vidal‐Alabró. Anna Vidal‐Alabró is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lloberas, Núria, et al.. (2025). State of Art of Dose Individualization to Support tacrolimus drug monitoring: What’s Next?. Transplant International. 38. 14201–14201. 1 indexed citations

Vidal‐Alabró, Anna, Raül Rigo‐Bonnin, Josep M. Grinyó, et al.. (2024). Guiding the starting dose of the once-daily formulation of tacrolimus in “de novo” adult renal transplant patients: a population approach. Frontiers in Pharmacology. 15. 1456565–1456565. 1 indexed citations

Vidal‐Alabró, Anna, Helena Colom, Pere Fontova, et al.. (2024). Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio. Nefrología (English Edition). 44(2). 204–216. 4 indexed citations

Lloberas, Núria, Anna Vidal‐Alabró, & Helena Colom. (2024). Customizing Tacrolimus Dosing in Kidney Transplantation: Focus on Pharmacogenetics. Therapeutic Drug Monitoring. 47(1). 141–151. 1 indexed citations

Fontova, Pere, Anna Vidal‐Alabró, Raül Rigo‐Bonnin, et al.. (2023). CYP3A5*3 and CYP3A4*22 Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach. Pharmaceutics. 15(12). 2699–2699. 5 indexed citations

Fontova, Pere, Anna Vidal‐Alabró, Raül Rigo‐Bonnin, et al.. (2023). The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations. Pharmaceutics. 15(5). 1481–1481. 6 indexed citations

Lloberas, Núria, Josep M. Grinyó, Helena Colom, et al.. (2023). A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction. Kidney International. 104(4). 840–850. 22 indexed citations

Gómez, F.J. Gíl, Xavier Fulladosa, Anna Vidal‐Alabró, et al.. (2022). The Role of Inflammasomes in Glomerulonephritis. International Journal of Molecular Sciences. 23(8). 4208–4208. 15 indexed citations

Fontova, Pere, Helena Colom, Raül Rigo‐Bonnin, et al.. (2021). Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation. Frontiers in Pharmacology. 12. 636048–636048. 14 indexed citations

10.

Simon‐Molas, Helga, Pere Fontova, Claudia Arnedo-Pac, et al.. (2021). TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Is Upregulated in Lymphocytes Stimulated with Concanavalin A. International Journal of Molecular Sciences. 22(14). 7436–7436. 6 indexed citations

11.

Casajoana, Anna, Fernando Guerrero‐Pérez, Amador García Ruiz de Gordejuela, et al.. (2021). Role of Gastrointestinal Hormones as a Predictive Factor for Long-Term Diabetes Remission: Randomized Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy, and Greater Curvature Plication. Obesity Surgery. 31(4). 1733–1744. 17 indexed citations

12.

Fontova, Pere, Inés Rama, Inés Llaudó, et al.. (2020). Mycophenolic acid interferes the transcriptional regulation and protein trafficking of maturation surface markers in dendritic cells. International Immunopharmacology. 91. 107025–107025. 4 indexed citations

13.

Fontova, Pere, Raül Rigo‐Bonnin, Anna Vidal‐Alabró, et al.. (2019). Measurement of calcineurin activity in peripheral blood mononuclear cells by ultra-high performance liquid chromatography-tandem mass spectrometry. Renal transplant recipients application (pharmacodynamic monitoring). Clinica Chimica Acta. 495. 287–293. 7 indexed citations

14.

Fontova, Pere, Raül Rigo‐Bonnin, Helena Colom, et al.. (2019). Validation and evaluation of four sample preparation methods for the quantification of intracellular tacrolimus in peripheral blood mononuclear cells by UHPLC-MS/MS. Clinica Chimica Acta. 503. 210–217. 7 indexed citations

15.

Guerrero‐Pérez, Fernando, Anna Casajoana, Carmen Gómez‐Vaquero, et al.. (2019). Changes in Bone Mineral Density in Patients with Type 2 Diabetes After Different Bariatric Surgery Procedures and the Role of Gastrointestinal Hormones. Obesity Surgery. 30(1). 180–188. 25 indexed citations

16.

Simon‐Molas, Helga, Claudia Arnedo-Pac, Pere Fontova, et al.. (2018). PI3K–Akt signaling controls PFKFB3 expression during human T-lymphocyte activation. Molecular and Cellular Biochemistry. 448(1-2). 187–197. 21 indexed citations

17.

Fontova, Pere, Raül Rigo‐Bonnin, Anna Vidal‐Alabró, et al.. (2018). Extended Release Tacrolimus (LCP-TAC) Prolongs Calcineurin Activity Inhibition During Drug Doses Intervals. Transplantation. 102(Supplement 7). S592–S593. 1 indexed citations

18.

Gómez-Valadés, Alícia G., Anna Vidal‐Alabró, Maria Molas, et al.. (2005). Overcoming Diabetes-Induced Hyperglycemia through Inhibition of Hepatic Phosphoenolpyruvate Carboxykinase (GTP) with RNAi. Molecular Therapy. 13(2). 401–410. 70 indexed citations

19.

Gómez-Valadés, Alícia G., Maria Molas, Anna Vidal‐Alabró, et al.. (2004). Copolymers of poly-l-lysine with serine and tryptophan form stable DNA vectors: implications for receptor-mediated gene transfer. Journal of Controlled Release. 102(1). 277–291. 9 indexed citations

20.

Molas, Maria, Alícia G. Gómez-Valadés, Anna Vidal‐Alabró, et al.. (2003). Receptor-Mediated Gene Transfer Vectors: Progress Towards Genetic Pharmaceuticals. Current Gene Therapy. 3(5). 468–485. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact